Quantbot Technologies LP Grows Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Quantbot Technologies LP boosted its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 437.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 56,560 shares of the real estate investment trust's stock after buying an additional 46,030 shares during the quarter. Quantbot Technologies LP's holdings in Sabra Health Care REIT were worth $1,053,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD lifted its position in Sabra Health Care REIT by 7.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 122,630 shares of the real estate investment trust's stock valued at $1,812,000 after purchasing an additional 8,554 shares during the period. Cetera Investment Advisers boosted its stake in shares of Sabra Health Care REIT by 34.1% in the 1st quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust's stock worth $6,007,000 after buying an additional 103,413 shares during the last quarter. Cetera Advisors LLC grew its holdings in shares of Sabra Health Care REIT by 996.2% in the first quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust's stock worth $2,209,000 after acquiring an additional 135,929 shares during the period. GAMMA Investing LLC increased its position in Sabra Health Care REIT by 40.0% during the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock valued at $57,000 after acquiring an additional 1,052 shares during the last quarter. Finally, Accel Wealth Management bought a new position in Sabra Health Care REIT in the second quarter valued at about $185,000. Institutional investors own 99.40% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Scotiabank upped their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a research report on Friday, October 11th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Truist Financial boosted their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Finally, Citigroup raised Sabra Health Care REIT from a "neutral" rating to a "buy" rating and raised their target price for the stock from $17.00 to $20.00 in a report on Friday, September 13th. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $18.71.

Sabra Health Care REIT Price Performance

NASDAQ:SBRA traded down $0.18 on Friday, reaching $18.73. 1,924,961 shares of the company's stock traded hands, compared to its average volume of 2,238,168. The firm has a market cap of $4.43 billion, a PE ratio of 45.68, a P/E/G ratio of 2.35 and a beta of 1.25. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. The stock has a 50-day simple moving average of $18.64 and a 200-day simple moving average of $16.84. Sabra Health Care REIT, Inc. has a 12 month low of $12.83 and a 12 month high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The business had revenue of $178.00 million during the quarter, compared to analysts' expectations of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period in the prior year, the firm posted $0.34 earnings per share. Equities research analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were issued a $0.30 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.41%. Sabra Health Care REIT's dividend payout ratio is currently 292.69%.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.